These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32115621)

  • 21. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology.
    Sequeira I; Rashid M; Tomás IM; Williams MJ; Graham TA; Adams DJ; Vigilante A; Watt FM
    Nat Commun; 2020 Nov; 11(1):5671. PubMed ID: 33168804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
    Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
    Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
    Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
    Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No difference in 4-nitroquinoline induced tumorigenesis between germ-free and colonized mice.
    Zhou YX; Fuentes-Creollo G; Ponce F; Langley SA; Jen KY; Celniker SE; Mao JH; Snijders AM
    Mol Carcinog; 2019 May; 58(5):627-632. PubMed ID: 30632250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
    Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ
    Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma.
    Kalish JM; Tang XH; Scognamiglio T; Zhang T; Gudas LJ
    Cancer Biol Ther; 2020 May; 21(5):400-411. PubMed ID: 32037955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
    Chen X; Hu Q; Wu T; Wang C; Xia J; Yang L; Cheng B; Chen X
    Int J Oncol; 2018 Mar; 52(3):733-742. PubMed ID: 29328386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.
    Hasina R; Martin LE; Kasza K; Jones CL; Jalil A; Lingen MW
    Cancer Prev Res (Phila); 2009 Apr; 2(4):385-93. PubMed ID: 19336725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
    Tamura T; Ichikawa T; Nakahata S; Kondo Y; Tagawa Y; Yamamoto K; Nagai K; Baba T; Yamaguchi R; Futakuchi M; Yamashita Y; Morishita K
    Cancer Res; 2017 May; 77(9):2363-2374. PubMed ID: 28209617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational genomics and recent advances in oral squamous cell carcinoma.
    Chai AWY; Lim KP; Cheong SC
    Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.
    Yang Z; Guan B; Men T; Fujimoto J; Xu X
    In Vivo; 2013; 27(4):473-84. PubMed ID: 23812217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma.
    Sagheer SH; Whitaker-Menezes D; Han JYS; Curry JM; Martinez-Outschoorn U; Philp NJ
    Methods Cell Biol; 2021; 163():93-111. PubMed ID: 33785171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions.
    Suzui M; Yoshimi N; Tanaka T; Mori H
    Mol Carcinog; 1995 Dec; 14(4):294-8. PubMed ID: 8519419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
    Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
    Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma.
    Razzo BM; Ludwig N; Hong CS; Sharma P; Fabian KP; Fecek RJ; Storkus WJ; Whiteside TL
    Carcinogenesis; 2020 Jul; 41(5):625-633. PubMed ID: 31245809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laser photobiomodulation does not alter clinical and histological characteristics of 4-NQO-induced oral carcinomas and leukoplakia in mice.
    Neculqueo GW; Estrázulas M; Cherubini K; Koth VS; Salum FG
    J Photochem Photobiol B; 2022 Dec; 237():112597. PubMed ID: 36399822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.
    Sheu JJ; Hua CH; Wan L; Lin YJ; Lai MT; Tseng HC; Jinawath N; Tsai MH; Chang NW; Lin CF; Lin CC; Hsieh LJ; Wang TL; Shih IeM; Tsai FJ
    Cancer Res; 2009 Mar; 69(6):2568-76. PubMed ID: 19276369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.